Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).

被引：0

作者：

Borazanci, Erkut Hasan

Jameson, Gayle S.

Snyder, Courtney Edwards

Thosani, Amar

Sckolnik, Steven

Korn, Ronald Lee

Rahmanuddin, Syed

Mocan, Dan

Pearse, Shelby

Gordon, Michael S.

Von Hoff, Daniel D.

Modasi, Aryan

Amini, Albert

机构：

[1] HonorHlth Res Inst, Scottsdale, AZ USA

[2] HonorHealth, Scottsdale, AZ USA

[3] Arizona Ctr Canc Care, Scottsdale, AZ USA

[4] Imaging Endpoints, Scottsdale, AZ USA

[5] City Of Hope, Duarte, CA USA

[6] Translat Genom Res Inst TGen, Phoenix, AZ USA

[7] HonorHealth, Phoenix, AZ USA

[8] Arizona Premier Surg, Scottsdale, AZ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期

关键词：

283-237-267-6887-6888; 3282-415-5268-2723-6700; 261-492-3532-2370-7650-2700; 261-3278; 613-4678-146-2641; 261-492-3532-2373; 261-137; 261-492-5651-2790; 6; 5; 3; 2; 1896; 3590; 176; 1;

D O I：

10.1200/JCO.2024.42.3_suppl.667

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：667 / 667

页数：1